The Effects of a Fiber-enriched Bakery Product on Glucose, Insulin Values and Appetite
NCT ID: NCT06032260
Last Updated: 2023-09-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2023-01-20
2023-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Glycemic and Hormone Responses After the Intake of Four Types of Bread.
NCT02653677
The Effect of Selected Fibres and Flours in Flat Bread on Post-prandial Blood Glucose Responses
NCT02671214
Glycaemic Index of Fibre-rich Flours in Healthy Volunteers
NCT05372666
The Effect of Consumption of Bread Types Made From Various Flours on Blood Glucose Fluctuations
NCT06288178
Effect of Three Fibres on Glycaemic and Insulinaemic Responses in Healthy Adult Volunteers
NCT02701270
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Ten Caucasian non-smoker healthy adult volunteers were enrolled starting from January 2023.
Participants were randomized to receive either the p-rich or p-standard. The order of administration of each product was randomized using a computer-generated sequence. The day of each test, fasting individuals underwent a blood sample collection, and weight and height measurements. Then, participants consumed 100 grams of the product within 20 minutes, while sitting. Blood samples were collected at 15, 30, 45, 60, 90, 120 minutes after the consumption of each food.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Enriched panettone
100 grams of panettone enriched with fiber. The added fiber is JAX Plus® (Heallo srl, Milano, Italy), a soluble fiber with Arabinoxylans from wheat and barley
Enriched panettone
Volunteers consumed 100 grams of panettone enriched with fiber (JAX Plus® (Heallo srl, Milano, Italy), a soluble fiber with Arabinoxylans from wheat and barley
Panettone standard
100 grams of panettone without fiber enrichment
Panettone standard
Volunteers consumed 100 grams of panettone standard
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Enriched panettone
Volunteers consumed 100 grams of panettone enriched with fiber (JAX Plus® (Heallo srl, Milano, Italy), a soluble fiber with Arabinoxylans from wheat and barley
Panettone standard
Volunteers consumed 100 grams of panettone standard
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 20-65 years;
* ability to provide informed written consent
Exclusion Criteria
* chronic diseases or pharmacological therapies;
* dietary restrictions;
* allergy or intolerance to the tested food
20 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Turin, Italy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Simona Bo
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Turin
Turin, AT, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PAN_2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.